150 related articles for article (PubMed ID: 6132341)
21. Dompamine receptors in the rat frontal cortex: an autoradiographic study.
Murrin LC; Kuhar MJ
Brain Res; 1979 Nov; 177(2):279-85. PubMed ID: 497833
[TBL] [Abstract][Full Text] [Related]
22. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
Cohen ML; Colbert WE
J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
[TBL] [Abstract][Full Text] [Related]
23. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
Hicks PE; Schoemaker H; Langer SZ
Eur J Pharmacol; 1984 Oct; 105(3-4):339-42. PubMed ID: 6150862
[TBL] [Abstract][Full Text] [Related]
24. Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
Andree TH; Mikuni M; Tong CY; Koenig JI; Meltzer HY
J Neurochem; 1986 Jan; 46(1):191-7. PubMed ID: 2866233
[TBL] [Abstract][Full Text] [Related]
25. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.
Stockmeier CA; DiCarlo JJ; Zhang Y; Thompson P; Meltzer HY
J Pharmacol Exp Ther; 1993 Sep; 266(3):1374-84. PubMed ID: 8103793
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone.
Chivers J; Jenner P; Marsden CD
Br J Pharmacol; 1987 Mar; 90(3):467-78. PubMed ID: 2882801
[TBL] [Abstract][Full Text] [Related]
27. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.
Doble A; Girdlestone D; Piot O; Allam D; Betschart J; Boireau A; Dupuy A; Guérémy C; Ménager J; Zundel JL
Br J Pharmacol; 1992 Jan; 105(1):27-36. PubMed ID: 1596688
[TBL] [Abstract][Full Text] [Related]
29. In vivo [3H]spiperone binding to the rat hippocampal formation: involvement of dopamine receptors.
Bischoff S; Bittiger H; Krauss J
Eur J Pharmacol; 1980 Dec; 68(3):305-15. PubMed ID: 7202494
[TBL] [Abstract][Full Text] [Related]
30. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
31. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
Leysen JE
J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
[TBL] [Abstract][Full Text] [Related]
32. Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists.
Sternberg EM; Trial J; Parker CW
J Immunol; 1986 Jul; 137(1):276-82. PubMed ID: 2423604
[TBL] [Abstract][Full Text] [Related]
33. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
[TBL] [Abstract][Full Text] [Related]
34. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
Peroutka SJ; Snyder SH
Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
[TBL] [Abstract][Full Text] [Related]
35. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
[TBL] [Abstract][Full Text] [Related]
37. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
38. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA
Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
[TBL] [Abstract][Full Text] [Related]
39. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
Costall B; Naylor RJ
Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
[TBL] [Abstract][Full Text] [Related]
40. Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT(2C) receptors in vivo.
Di Matteo V; Cacchio M; Di Giulio C; Di Giovanni G; Esposito E
Pharmacol Biochem Behav; 2002 Apr; 71(4):607-13. PubMed ID: 11888552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
